Am J Clin Oncol 2020 Mar
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
Related Questions
In the adjuvant setting, what boost dose to vascular areas can be safely applied, assuming one has all the tech to reliably breath hold the patient an...
New comment by Radiation Oncologist at Memorial Sloan-Kettering Cancer Center ( November 4, 2021)
The data are very limited to be sure, but a meta-analysis of the ESPAC-1 trial combined with other smaller randomized trials showed a DFS advantage with the use of radiation f...